−1.68USD
−106.14 MUSD
19.17 MUSD
68.93 M
About Cellectis S.A.
Sector
CEO
André Choulika
Headquarters
Paris
Website
Employees (FY)
237
Founded
1999
FIGI
BBG0084L1XN2
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
